Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Polycystic Ovary Syndrome × Nimodipine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Anovulation 1

Interventions

Metformin 131 Clomiphene 45 Letrozole 35 Inositol 31 Folic Acid 16 Progesterone 14 Exercise 14 Chorionic Gonadotropin 13 drospirenone and ethinyl estradiol combination 12 Ethinyl Estradiol 12 Caloric Restriction 12 Estradiol 11 cetrorelix 10 Contraceptives, Oral 10 Spironolactone 9 Pioglitazone 9 Cholecalciferol 9 Triptorelin Pamoate 8 Tablets 8 High-Intensity Interval Training 8 Diet 8 Menotropins 7 Acupuncture Therapy 7 drospirenone 6 Thioctic Acid 6 Ovidrel 6 Liraglutide 6 Gonadotropins 6 Flutamide 6 Exenatide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01672801 2020-08-11

NIMO

Boston IVF

Phase NA Completed

18 enrolled 7 charts

Anovulation, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡